Montclair, NJ, United States of America

Andrew J M Murphy


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Andrew J M Murphy

Introduction

Andrew J M Murphy is an accomplished inventor based in Montclair, NJ (US). He has made significant contributions to the field of pharmacology through his innovative work on G protein-coupled receptors. His research focuses on developing methods that enhance the identification of compounds that interact with these critical cellular receptors.

Latest Patents

Andrew holds a patent titled "Methods for identifying G protein coupled receptor effectors." This invention provides a rapid and effective assay for screening and identifying pharmaceutically effective compounds that specifically interact with and modulate the activity of cellular receptors or ion channels. The assay enables the rapid screening of large numbers of polypeptides in a yeast expression library, allowing for the identification of polypeptides that induce or antagonize receptor bioactivity. This method is particularly useful for identifying surrogate ligands for orphan receptors.

Career Highlights

Andrew J M Murphy is associated with Cadus Pharmaceutical Corp., where he applies his expertise in pharmacology and receptor biology. His work has contributed to advancements in drug discovery and development, particularly in the area of receptor-targeted therapies.

Collaborations

Some of Andrew's notable coworkers include Christine A Klein and Dana M Fowlkes. Their collaborative efforts have furthered research in the field and enhanced the understanding of receptor interactions.

Conclusion

Andrew J M Murphy's innovative contributions to the field of pharmacology, particularly through his patent on G protein-coupled receptors, highlight his role as a significant inventor. His work continues to influence drug discovery and development, paving the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…